The mechanism of androgen and estrogen synergism in the chick oviduct. Estrogen-modulated changes in cytoplasmic androgen receptor concentrations

Richard Tokarz, R. W. Harrison, S. S. Seaver

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

To investigate why androgens are inactive alone, but act synergistically with estrogen to stimulate the chick oviduct, we examined the effects of estradiol on cytoplasmic testosterone receptor levels in the oviduct magna of White Leghorn chicks. Cytosol obtained from magna of 5-day-old chicks bound low levels of [3H]-testosterone (0.58 pmol/g of magnum). Seven days of estrogen treatment caused a 10-fold increase in the number of these binding sites. These sites decreased during estrogen withdrawal to levels similar to those found in the untreated chick. [3H]Testosterone binding again increased within 2 days after the administration of estrogen to withdrawn chicks. When administered alone to the estrogen-pretreated chick, testosterone, and, to a greater extent, dihydrotestosterone, were effective in stimulating magnum growth and maintaining ovalbumin mRNA levels as long as testosterone receptor levels remained elevated. These effects were not blocked by the concurrent administration of the anti-estrogen tamoxifen. Thus, androgen stimulation of the magnum was not dependent on the effects of low levels of estrogen remaining in estrogen-pretreated chicks. These results suggest that estrogen treatment is required for the induction and maintenance of the androgen cytoplasmic receptor and that the ability of androgens to modulate magnum growth and ovalbumin mRNA levels correlates with the concentration of this receptor. Inadequate levels of androgen receptor in untreated chicks or chicks, withdrawn from estrogen treatment for a period of weeks may be one factor explaining why testosterone and dihydrotestosterone alone do not stimulate the oviducts of these chicks.

Original languageEnglish
Pages (from-to)9178-9184
Number of pages7
JournalJournal of Biological Chemistry
Volume254
Issue number18
StatePublished - Dec 1 1979
Externally publishedYes

Fingerprint

Oviducts
Androgen Receptors
Cytoplasmic and Nuclear Receptors
Androgens
Estrogens
Testosterone
Dihydrotestosterone
Ovalbumin
Messenger RNA
Tamoxifen
Growth
Cytosol
Estradiol
Binding Sites
Maintenance

ASJC Scopus subject areas

  • Biochemistry

Cite this

The mechanism of androgen and estrogen synergism in the chick oviduct. Estrogen-modulated changes in cytoplasmic androgen receptor concentrations. / Tokarz, Richard; Harrison, R. W.; Seaver, S. S.

In: Journal of Biological Chemistry, Vol. 254, No. 18, 01.12.1979, p. 9178-9184.

Research output: Contribution to journalArticle

@article{5b6d68c05509454fb799eb9db2cb3ef6,
title = "The mechanism of androgen and estrogen synergism in the chick oviduct. Estrogen-modulated changes in cytoplasmic androgen receptor concentrations",
abstract = "To investigate why androgens are inactive alone, but act synergistically with estrogen to stimulate the chick oviduct, we examined the effects of estradiol on cytoplasmic testosterone receptor levels in the oviduct magna of White Leghorn chicks. Cytosol obtained from magna of 5-day-old chicks bound low levels of [3H]-testosterone (0.58 pmol/g of magnum). Seven days of estrogen treatment caused a 10-fold increase in the number of these binding sites. These sites decreased during estrogen withdrawal to levels similar to those found in the untreated chick. [3H]Testosterone binding again increased within 2 days after the administration of estrogen to withdrawn chicks. When administered alone to the estrogen-pretreated chick, testosterone, and, to a greater extent, dihydrotestosterone, were effective in stimulating magnum growth and maintaining ovalbumin mRNA levels as long as testosterone receptor levels remained elevated. These effects were not blocked by the concurrent administration of the anti-estrogen tamoxifen. Thus, androgen stimulation of the magnum was not dependent on the effects of low levels of estrogen remaining in estrogen-pretreated chicks. These results suggest that estrogen treatment is required for the induction and maintenance of the androgen cytoplasmic receptor and that the ability of androgens to modulate magnum growth and ovalbumin mRNA levels correlates with the concentration of this receptor. Inadequate levels of androgen receptor in untreated chicks or chicks, withdrawn from estrogen treatment for a period of weeks may be one factor explaining why testosterone and dihydrotestosterone alone do not stimulate the oviducts of these chicks.",
author = "Richard Tokarz and Harrison, {R. W.} and Seaver, {S. S.}",
year = "1979",
month = "12",
day = "1",
language = "English",
volume = "254",
pages = "9178--9184",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "18",

}

TY - JOUR

T1 - The mechanism of androgen and estrogen synergism in the chick oviduct. Estrogen-modulated changes in cytoplasmic androgen receptor concentrations

AU - Tokarz, Richard

AU - Harrison, R. W.

AU - Seaver, S. S.

PY - 1979/12/1

Y1 - 1979/12/1

N2 - To investigate why androgens are inactive alone, but act synergistically with estrogen to stimulate the chick oviduct, we examined the effects of estradiol on cytoplasmic testosterone receptor levels in the oviduct magna of White Leghorn chicks. Cytosol obtained from magna of 5-day-old chicks bound low levels of [3H]-testosterone (0.58 pmol/g of magnum). Seven days of estrogen treatment caused a 10-fold increase in the number of these binding sites. These sites decreased during estrogen withdrawal to levels similar to those found in the untreated chick. [3H]Testosterone binding again increased within 2 days after the administration of estrogen to withdrawn chicks. When administered alone to the estrogen-pretreated chick, testosterone, and, to a greater extent, dihydrotestosterone, were effective in stimulating magnum growth and maintaining ovalbumin mRNA levels as long as testosterone receptor levels remained elevated. These effects were not blocked by the concurrent administration of the anti-estrogen tamoxifen. Thus, androgen stimulation of the magnum was not dependent on the effects of low levels of estrogen remaining in estrogen-pretreated chicks. These results suggest that estrogen treatment is required for the induction and maintenance of the androgen cytoplasmic receptor and that the ability of androgens to modulate magnum growth and ovalbumin mRNA levels correlates with the concentration of this receptor. Inadequate levels of androgen receptor in untreated chicks or chicks, withdrawn from estrogen treatment for a period of weeks may be one factor explaining why testosterone and dihydrotestosterone alone do not stimulate the oviducts of these chicks.

AB - To investigate why androgens are inactive alone, but act synergistically with estrogen to stimulate the chick oviduct, we examined the effects of estradiol on cytoplasmic testosterone receptor levels in the oviduct magna of White Leghorn chicks. Cytosol obtained from magna of 5-day-old chicks bound low levels of [3H]-testosterone (0.58 pmol/g of magnum). Seven days of estrogen treatment caused a 10-fold increase in the number of these binding sites. These sites decreased during estrogen withdrawal to levels similar to those found in the untreated chick. [3H]Testosterone binding again increased within 2 days after the administration of estrogen to withdrawn chicks. When administered alone to the estrogen-pretreated chick, testosterone, and, to a greater extent, dihydrotestosterone, were effective in stimulating magnum growth and maintaining ovalbumin mRNA levels as long as testosterone receptor levels remained elevated. These effects were not blocked by the concurrent administration of the anti-estrogen tamoxifen. Thus, androgen stimulation of the magnum was not dependent on the effects of low levels of estrogen remaining in estrogen-pretreated chicks. These results suggest that estrogen treatment is required for the induction and maintenance of the androgen cytoplasmic receptor and that the ability of androgens to modulate magnum growth and ovalbumin mRNA levels correlates with the concentration of this receptor. Inadequate levels of androgen receptor in untreated chicks or chicks, withdrawn from estrogen treatment for a period of weeks may be one factor explaining why testosterone and dihydrotestosterone alone do not stimulate the oviducts of these chicks.

UR - http://www.scopus.com/inward/record.url?scp=0018664843&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018664843&partnerID=8YFLogxK

M3 - Article

C2 - 479187

AN - SCOPUS:0018664843

VL - 254

SP - 9178

EP - 9184

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 18

ER -